Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
business development
Pharma
Amid ongoing launches, Novo eyes rare disease leadership
As Novo advances its rare disease ambitions, the success of a hemophilia launch and late-stage sickle cell disease trial will be key.
Fraiser Kansteiner
Mar 7, 2025 9:20am
Biogen places chips behind 4 new drugs as MS competition mounts
Feb 12, 2025 11:35am
Sanofi aims to grow Beyfortus after blockbuster sales year
Jan 30, 2025 11:45am
JPM25: Servier chief on 'staying authentic' as firm grows reach
Jan 23, 2025 1:00pm
2024's top biopharma M&A deals
Jan 13, 2025 3:00am
Trump's nominee to chair the FTC could bode well for pharma M&A
Dec 11, 2024 11:25am
